The Business Research Company's X-linked Hypophosphatemia Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 The Business Research Company's Latest Report Explores ...

A second consideration is hypocalcemia—bone-modifying agents inhibit osteoclast activity and increase the risk of hypocalcemia and hypophosphatemia. Patients with hypoparathyroidism, renal disease, ...

Background and Aims Hypophosphatemia is a common yet often overlooked metabolic disturbance in critically ill children, linked to prolonged mechanical ventilation, extubation failure, extended ...

Retifanlimab-dlwr (Zynyz) was granted approval from the FDA for treatment of locally recurrent or metastatic squamous cell ...

Conditions that are often considered metabolic bone disorders include osteoporosis, osteomalacia, rickets, hypophosphatemia, and Paget’s disease. Most commonly, these disorders are caused by ...

BACKGROUND: Recent studies have highlighted the deleterious role of high phosphate intake in hypertension by means of ...